当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CRISPR–Cas9 hits its target in amyloidosis
Nature Medicine ( IF 58.7 ) Pub Date : 2022-10-12 , DOI: 10.1038/d41591-022-00101-4
Thiago Carvalho

Nature Medicine explores the latest translational and clinical research news, with an analysis of Intellia and Regeneron’s gene-editing treatment, which reduced levels of transthyretin in patients.

中文翻译:

CRISPR–Cas9 在淀粉样变性中发挥作用

Nature Medicine 探索最新的转化和临床研究新闻,分析了 Intellia 和 Regeneron 的基因编辑治疗,该治疗降低了患者体内转甲状腺素蛋白的水平。
更新日期:2022-10-12
down
wechat
bug